International Business Machines CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Anne Robinson, Senior Vice President at IBM Corporation, reported transactions involving restricted stock units and common stock.
NYSE
Ramon Laguarta, a Director at IBM, reported a transaction involving deferred compensation shares.
NYSE
Martha E. Pollack, a Director at IBM, reported a transaction involving deferred compensation shares under the company's equity award plan.
NYSE
Michael Miebach, a Director at IBM, reported a transaction involving deferred compensation plan shares on June 30, 2026.
NYSE
Andrew N. Liveris, a Director at IBM, reported a transaction involving deferred compensation shares on June 30, 2026.
NYSE
Michelle J. Howard, a Director at IBM, reported a transaction involving deferred compensation shares on June 30, 2026.
NYSE
Alex Gorsky, a Director at IBM, reported a transaction involving deferred compensation shares on June 30, 2026.
NYSE
David N. Farr, a Director at IBM, reported a transaction involving deferred compensation shares under the company's equity award plan.
NYSE
IBM Director Marianne Brown reported a transaction involving deferred compensation shares on June 30, 2026.
NYSE
Nicolas A. Fehring, VP Controller at IBM Corporation, acquired 400 shares of common stock on June 4, 2026.
NYSE
IBM Director Ramon Laguarta defers compensation into 126 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Marianne Catherine Brown deferred fees into 377 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Thomas Buberl deferred fees into 377 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director David N. Farr deferred director fees into 243 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Alex Gorsky defers compensation into 444 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Michelle J. Howard deferred fees into 264 Promised Fee Shares, increasing her beneficial ownership of derivative securities to 16,311.
NYSE
IBM Director Andrew N. Liveris defers compensation into 403 Promised Fee Shares, increasing his beneficial ownership to 43,878 shares.
NYSE
IBM Director Frederick William McNabb III deferred fees into 377 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Michael Miebach deferred board fees into 377 Promised Fee Shares, increasing his beneficial ownership to 3,929 shares.
NYSE
IBM Director Peter R. Voser deferred fees into 413 Promised Fee Shares under the company's deferred compensation plan, valued at $242.39 per share.
NYSE
IBM Director Frederick H. Waddell defers compensation into 403 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Director Alfred W. Zollar acquired 377 Promised Fee Shares through a deferred compensation plan, increasing his beneficial ownership to 9,557 shares.
NYSE
IBM Director Martha E. Pollack defers compensation into 243 Promised Fee Shares under the company's deferred compensation plan.
NYSE
IBM Senior Vice President Anne Robinson was granted 6,341 Restricted Stock Units and 25,363 Employee Stock Options on February 26, 2026.
NYSE
IBM Senior Vice President Nickle Jaclyn Lamoreaux was granted 6,285 Restricted Stock Units and 25,138 Employee Stock Options.
NYSE
IBM's Chairman, President & CEO, Arvind Krishna, received grants of 22,518 Restricted Stock Units and 90,071 Employee Stock Options.
NYSE
IBM's Senior VP and CFO, James J. Kavanaugh, reported the acquisition of 10,364 Restricted Stock Units and 41,455 Employee Stock Options.
NYSE
IBM's VP, Controller, Nicolas A. Fehring, acquired 2,844 restricted stock units and 7,584 employee stock options, signaling increased insider ownership.
NYSE
IBM Vice Chairman Gary D. Cohn reported the acquisition of restricted stock units and employee stock options as part of his compensation package.
NYSE
IBM's Senior Vice President, Robert David Thomas, acquired 10,565 restricted stock units and 42,258 employee stock options.